REGENERATIVE

Exosomes & birth tissue biologics.

Next-generation regenerative therapies — processed under cGMP conditions in FDA-registered facilities, validated through nanoparticle tracking analysis, and delivered fresh (never frozen) to preserve maximum biological activity.

Schedule a consultation → Common questions

Quality Standards

RegulatoryFDA registered
ProcessingcGMP · 21 CFR 1271
Clean roomsISO 5 · 24/7 monitored
StorageNever frozen
SourceWharton's Jelly MSC
ValidationNTA particle tracking
Safety & production

Regenerative medicine, rigorously processed.

Every product meets the full FDA registration and cGMP processing standards for HCT/Ps — with fresh-processing protocols that preserve biological activity.

FDA registered

FDA Registered Facility

cGMP processing facility with full FDA registration and compliance to 21 CFR Part 1271 for human cells, tissues, and cellular and tissue-based products (HCT/Ps). Quality assurance embedded at every production step.

Never frozen

Fresh, Never Frozen

Birth tissue is processed immediately upon receipt and is never frozen — preserving maximum biological activity, signaling capacity, and growth factor integrity in every finished product.

Next-generation

Next-Generation Biologics

Acellular exosome products and Wharton's Jelly MSC-derived therapies that simplify storage and handling while delivering concentrated bioactive cargo — growth factors, cytokines, and signaling molecules.

Common questions

What to know about regenerative biologics.

What are exosomes? +
In a wound that has stalled, the underlying problem is signaling — inflammation stays switched on and rebuilding never starts. Exosomes are the signaling packets cells use to change that. These nanoscale vesicles (30–150 nm) deliver growth factors, cytokines, and nucleic acids that help quiet the inflammatory loop, stimulate new blood vessel formation (angiogenesis), and support matrix remodeling and re-epithelialization. And because exosome products are acellular — vesicles, not living cells — storage, handling, and regulatory considerations are simpler than cell-based therapies.
What birth tissue products are available? +
Our regenerative portfolio includes exosome products (NTA-validated for concentration, particle size, and batch consistency), Wharton's Jelly MSC-derived therapies, and fresh-processed placental biologics. All products are processed in ISO 5 classified clean rooms with 24/7 environmental monitoring, inside an FDA-registered cGMP facility. Every batch ships fresh — never frozen — preserving maximum biological activity.
What are the clinical applications? +
Regenerative biologics support a range of wound care and musculoskeletal protocols — including chronic wound healing, inflammation modulation, soft tissue regeneration, and combination therapy alongside allografts and collagen programs. Albacete MedDev provides full operational and compliance infrastructure — documentation support, coding guidance, storage and handling protocols, and clinical education — so your practice can implement these therapies with confidence.
Ready when you are

Add regenerative biologics to your program.

A 30-minute consultation to walk through product selection, clinical protocols, and compliance infrastructure.

Schedule a consultation → Explore the portfolio